IMV Inc. (IMVIQ)
OTCMKTS: IMVIQ · Delayed Price · USD
0.0000
0.00 (0.00%)
Apr 23, 2024, 10:13 AM EDT - Market closed
IMV Inc. Revenue
In the year 2022, IMV Inc. had annual revenue of $240.15K with 63.50% growth. Revenue in the quarter ending December 31, 2022 was $111.68K with 308.42% year-over-year growth.
Revenue (ttm)
$240.15K
Revenue Growth
+63.50%
P/S Ratio
0.00
Revenue / Employee
$3,812
Employees
63
Market Cap
12.00 USD
Revenue Chart
* The company reports in CAD currency but revenue data is shown in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 240.15K | 93.27K | 63.50% |
Dec 31, 2021 | 146.88K | -29.60K | -16.77% |
Dec 31, 2020 | 176.47K | -257.12K | -59.30% |
Dec 31, 2019 | 433.59K | 75.81K | 21.19% |
Dec 31, 2018 | 357.78K | 183.37K | 105.14% |
Dec 31, 2017 | 174.41K | 77.93K | 80.78% |
Dec 31, 2016 | 96.48K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 371.62B |
Johnson & Johnson | 85.16B |
Merck & Co. | 60.12B |
AbbVie | 54.32B |
Novartis AG | 49.92B |
AstraZeneca | 45.81B |
Thermo Fisher | 42.86B |
Abbott Laboratories | 40.11B |
IMVIQ News
- 9 months ago - IMV Inc. Announces Update on CCAA Proceedings and Sales and Investment Solicitation Process - Business Wire
- 1 year ago - IMV Receives NASDAQ Delisting Notice - Business Wire
- 1 year ago - Horizon Technology Finance Announces First Quarter 2023 Financial Results - PRNewsWire
- 1 year ago - IMV Initiates Restructuring Proceedings Under the CCAA to Complete the Review of its Strategic Alternatives - Business Wire
- 1 year ago - IMV Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency - Business Wire
- 1 year ago - IMV Inc. Announces Changes to Its Board of Directors - Business Wire
- 1 year ago - IMV Inc. Announces Strategic Update as well as Fourth Quarter and Full Year 2022 Financial and Operational Results - Business Wire
- 1 year ago - IMV Inc. to Announce Fourth Quarter and Fiscal Year 2022 Results and Host a Conference Call and Webcast on March 16, 2023 - Business Wire